Earnings Summary : Emergent BioSolutions Q4 - Emergent BioSolutions ( NYSE : EBS )

<p>The earnings results for Emergent BioSolutions (NYSE:<a href="https://www.benzinga.com/quote/EBS">EBS</a>) for Q4 were made public on Thursday, February 26, 2026 at 04:05 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Emergent BioSolutions missed estimated earnings by -234.38%, reporting an EPS of $-0.43 versus an estimate of $0.32.</p>
<p>Revenue was down $46.00 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>The company beat on EPS by $1.09 in the previous quarter, leading to a 36.6% increase share price change the next day.</p>
<p>To track all earnings releases for Emergent BioSolutions <a href="https://www.benzinga.com/quote/EBS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<p>
<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom">Market News and Data brought to you by Benzinga APIs</a>
</p>
<p>© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.</p>
<p>To add Benzinga News as your preferred source on Google, <a href="https://google.com/preferences/source?q=https%3A%2F%2Fwww.benzinga.com">click here</a>.</p>